FDM PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FDM PHARMA
Largest movements
- Cash -€632,718
down €632,718 (-54.1%), from €1.2m to €537,485
mainly Current investments (-€500,000) and Other debts (-€361,868)
- Current investments +€500,000
new in 2025: €500,000
- Intangible fixed assets -€238,293
down €238,293 (-44.0%), from €541,936 to €303,642
- Tangible fixed assets -€62,718
down €62,718 (-11.5%), from €544,197 to €481,479
of which Other tangible fixed assets: -€32,496
- Other debts -€361,868
down €361,868 (-99.8%), from €362,567 to €699
- Reserves +€357,146
up €357,146 (+32.0%), from €1.1m to €1.5m
of which Distributable reserves: +€230,846
- Trade debts -€216,215
down €216,215 (-75.4%), from €286,590 to €70,376
- Debts after one year -€168,918
down €168,918 (-20.2%), from €837,320 to €668,402
- Gross operating margin +€144,675
up €144,675 (+16.1%), from €899,567 to €1.0m
- Staff costs +€76,595
up €76,595 (+95.3%), from €80,333 to €156,927
- Taxes +€19,170
up €19,170 (+10.9%), from €175,207 to €194,377
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,266,880 | €2,840,351 | -€426,529 | -13.1% |
| Fixed assets | 21/28 | €1,520,873 | €1,219,862 | -€301,011 | -19.8% |
| Intangible fixed assets | 21 | €541,936 | €303,642 | -€238,293 | -44.0% |
| Tangible fixed assets | 22/27 | €544,197 | €481,479 | -€62,718 | -11.5% |
| Land and buildings | 22 | €130,890 | €120,263 | -€10,627 | -8.1% |
| Plant, machinery and equipment | 23 | €14,636 | €12,215 | -€2,422 | -16.5% |
| Furniture and vehicles | 24 | €14,535 | €12,217 | -€2,318 | -15.9% |
| Leasing and similar rights | 25 | €91,731 | €76,876 | -€14,856 | -16.2% |
| Other tangible fixed assets | 26 | €292,404 | €259,909 | -€32,496 | -11.1% |
| Financial fixed assets | 28 | €434,741 | €434,741 | = | 0.0% |
| Current assets | 29/58 | €1,746,007 | €1,620,489 | -€125,518 | -7.2% |
| Stocks and contracts in progress | 3 | €300,365 | €330,031 | +€29,665 | +9.9% |
| Stocks | 30/36 | €300,365 | €330,031 | +€29,665 | +9.9% |
| Amounts receivable within one year | 40/41 | €30,144 | €25,501 | -€4,643 | -15.4% |
| Trade receivables | 40 | €21,570 | €13,893 | -€7,677 | -35.6% |
| Other amounts receivable | 41 | €8,574 | €11,608 | +€3,034 | +35.4% |
| Current investments | 50/53 | - | €500,000 | +€500,000 | |
| Cash at bank and in hand | 54/58 | €1,170,203 | €537,485 | -€632,718 | -54.1% |
| Deferred charges and accrued income | 490/1 | €245,294 | €227,472 | -€17,822 | -7.3% |
| Total equity and liabilities | 10/49 | €3,266,880 | €2,840,351 | -€426,529 | -13.1% |
| Equity | 10/15 | €1,492,686 | €1,849,832 | +€357,146 | +23.9% |
| Contributions | 10/11 | €14,260 | €14,260 | = | 0.0% |
| Reserves | 13 | €1,114,745 | €1,471,890 | +€357,146 | +32.0% |
| Tax-exempt reserves | 132 | €84,200 | €210,500 | +€126,300 | +150.0% |
| Distributable reserves | 133 | €1,030,545 | €1,261,390 | +€230,846 | +22.4% |
| Profit (loss) carried forward | 14 | €363,682 | €363,682 | = | 0.0% |
| Amounts payable | 17/49 | €1,774,193 | €990,519 | -€783,675 | -44.2% |
| Amounts payable after more than one year | 17 | €837,320 | €668,402 | -€168,918 | -20.2% |
| Financial debts | 170/4 | €837,320 | €668,402 | -€168,918 | -20.2% |
| Amounts payable within one year | 42/48 | €936,873 | €322,116 | -€614,757 | -65.6% |
| Current portion of amounts payable after more than one year | 42 | €187,001 | €167,771 | -€19,230 | -10.3% |
| Trade debts | 44 | €286,590 | €70,376 | -€216,215 | -75.4% |
| Suppliers | 440/4 | €286,590 | €70,376 | -€216,215 | -75.4% |
| Taxes, remuneration and social security | 45 | €100,716 | €83,271 | -€17,445 | -17.3% |
| Taxes | 450/3 | €81,338 | €52,263 | -€29,074 | -35.7% |
| Remuneration and social security | 454/9 | €19,378 | €31,008 | +€11,630 | +60.0% |
| Other amounts payable | 47/48 | €362,567 | €699 | -€361,868 | -99.8% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €80,333 | €156,927 | +€76,595 | +95.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €302,174 | €303,401 | +€1,227 | +0.4% |
| Other operating charges | 640/8 | €4,287 | €6,004 | +€1,717 | +40.1% |
| Gross operating margin | 9900 | €899,567 | €1,044,242 | +€144,675 | +16.1% |
| Operating profit (loss) | 9901 | €512,774 | €577,910 | +€65,136 | +12.7% |
| Financial income | 75/76B | €4,548 | €3,291 | -€1,258 | -27.6% |
| Recurring financial income | 75 | €4,548 | €3,291 | -€1,258 | -27.6% |
| Financial charges | 65/66B | €33,365 | €29,677 | -€3,687 | -11.1% |
| Recurring financial charges | 65 | €33,365 | €29,677 | -€3,687 | -11.1% |
| Profit (loss) for the period before taxes | 9903 | €483,957 | €551,523 | +€67,566 | +14.0% |
| Income taxes | 67/77 | €175,207 | €194,377 | +€19,170 | +10.9% |
| Profit (loss) for the period | 9904 | €308,750 | €357,146 | +€48,396 | +15.7% |
| Transfer to tax-exempt reserves | 689 | €84,200 | €126,300 | +€42,100 | +50.0% |
| Profit (loss) for the period to be appropriated | 9905 | €224,550 | €230,846 | +€6,296 | +2.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.